Chartwell Pharmaceuticals LLC., operates a pristine manufacturing facility in Congers, New York. Facility expansion beginning in 2019 will allow for additional manufacturing, packaging, lab and warehouse space as well as add to our manufacturing capabilities and triple our production volume. We are also in the process of acquiring additional facilities and equipment. Together, the expansion and acquisition will greatly diversify and increase our dosage form and manufacturing capabilities.
The Congers facility is fully-cGMP compliant and has been operational for over 20 years.